Finland· FI-REL-REL25787
Normosang
A hemin product containing human hemin, registered in Finland by Recordati Rare Diseases. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Hemin is registered in 11 of 19 countries.
Countries holding a registration under ATC B06AB01 (hemin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Hemin · ATC B06AB01
11 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Human hemin
- Manufacturer
- Recordati Rare Diseases
- Country
- Finland (FI)
- ATC code
- B06AB01
- ATC class
- Hemin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
90 interactions on record for hemin.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hemin · interactions on record
90 records
- 21 severe
- 69 moderate
Most severe, free to view
- EstradiolD11AX34severe
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hemin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNormosang 25 mg/mlRecordati Rare Diseases
- IrelandNormosang 25 mg/ml, concentrate for solution for infusionRecordati Rare Diseases
- IcelandNormosangRecordati Rare Diseases
- NorwayNormosangRecordati Rare Diseases
- SwedenNormosang 25 mg/ml Koncentrat till infusionsvätska, lösningRecordati Rare Diseases
- GermanyNormosangRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Normosang
- Belgium · Normosang
- Czechia · Normosang
- Germany · Normosang
- Denmark · Normosang
- Estonia · Normosang
- Spain · Normosang
- France · Normosang
- United Kingdom (Northern Ireland) · Normosang
- Croatia · Normosang
- Hungary · Normosang
- Ireland · Normosang
- Iceland · Normosang
- Italy · Normosang
- Lithuania · Normosang
- Luxembourg · Normosang
- Latvia · Normosang
- Malta · Normosang
- Netherlands · Normosang
- Norway · Normosang
- Poland · Human Hemin Orphan Europe
- Portugal · Normosang
- Sweden · Normosang
- Slovenia · Normosang
- Slovakia · Normosang
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eebf39ab-0953-4bfd-982a-5850ec6b2864 GET /v1/drugs/eebf39ab-0953-4bfd-982a-5850ec6b2864?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusiokonsentraatti, liuosta varten",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "25 mg/ml",
"atc_label": "hemiini",
"ma_number": "21924",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL25787",
"authorised_at": "2008-10-06"
}See everything about hemin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.